BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 18360115)

  • 1. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma arising in keratoacanthoma: a neglected phenomenon in the elderly.
    Weedon DD; Malo J; Brooks D; Williamson R
    Am J Dermatopathol; 2010 Jul; 32(5):423-6. PubMed ID: 20414090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infundibular (follicular) and infundibulocystic squamous cell carcinoma: a clinicopathological and immunohistochemical study.
    Misago N; Inoue T; Toda S; Narisawa Y
    Am J Dermatopathol; 2011 Oct; 33(7):687-94. PubMed ID: 21937907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Keratoacanthoma or carcinoma? Histological differential diagnosis].
    Hundeiker M
    Pathologe; 1979 Nov; 1(1):50-2. PubMed ID: 555520
    [No Abstract]   [Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma.
    Beham A; Regauer S; Soyer HP; Beham-Schmid C
    Adv Anat Pathol; 1998 Sep; 5(5):269-80. PubMed ID: 10021894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
    Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
    Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
    Ribeiro D; Narikawa S; Marques ME
    Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
    Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
    J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic lichen planus-like reactions combined with infundibulocystic hyperplasia: pathway to neoplasia.
    Kossard S; Thompson C; Duncan GM
    Arch Dermatol; 2004 Oct; 140(10):1262-7. PubMed ID: 15492191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratoacanthoma: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):254-61. PubMed ID: 20541676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin squamous cell carcinoma and its precancerous conditions].
    Laukkanen A; Rummukainen J; Kivinen P; Lappalainen K
    Duodecim; 2006; 122(1):71-9. PubMed ID: 16509192
    [No Abstract]   [Full Text] [Related]  

  • 14. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell and squamous cell carcinomas. Clinico-histological features.
    Annessi G; Baliva G
    Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
    Ho T; Horn T; Finzi E
    Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermoid carcinoma or keratoacanthoma?].
    Estruch R; Aguilera MT; Cardellach F; Palou J
    Med Clin (Barc); 1986 Oct; 87(11):477. PubMed ID: 3784650
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
    Connolly M; Narayan S; Oxley J; de Berker DA
    Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for squamous cell carcinoma of the skin with two illustrative cases and literature review.
    Owczarek W; Majewski S; Schwartz RA
    Acta Dermatovenerol Croat; 2011; 19(1):21-7. PubMed ID: 21489362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.